Chronic respiratory disease originating in the perinatal period

P16_CHRONIC_RESPI_DISEA_ORIGINA_PERINA_PERIOD

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 P27
  • Cause of death: ICD-10 P27

2 out of 7 registries used, show all original rules.

84

4. Check minimum number of events

None

84

5. Include endpoints

None

84

6. Filter based on genotype QC (FinnGen only)

66

Control definitions (FinnGen only)

Control exclude
P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P2
Name in latin
Morbus respiratorius chronicus origine perinatalis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2666 1099 1567
Only index persons 1532 618 914
Unadjusted period prevalence (%)
Whole population 0.04 0.03 0.04
Only index persons 0.03 0.02 0.03
Median age at first event (years)
Whole population - 0.00 0.00
Only index persons 0.03 0.00 0.04

-FinnGen-

Key figures

All Female Male
Number of individuals 66 36 30
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 0.11 0.15 0.07

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
81
Matched controls
806
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
+∞
103.9
76
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
134.4
101.7
57
14
602
Kela drug reimbursment
Children's severe malnutrition
31.5
49.2
38
22
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
21.6
45.0
57
80
P07.2
ICD-10 Finland
Extreme immaturity
+∞
43.7
38
*
J45.1
ICD-10 Finland
Nonallergic asthma
18.3
40.2
46
54
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
34.9
31
*
H35.1
ICD-10 Finland
Retinopathy of prematurity
+∞
25.3
23
*
P07.3
ICD-10 Finland
Other preterm infants
34.7
24.0
31
14
R03BA02
ATC
budesonide; inhalant
8.9
22.0
41
83
WX722
NOMESCO Finland
PEEP
98.4
20.8
22
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
10.1
19.4
27
38
R4110
NOMESCO Finland
Physiotherapy
7.7
19.2
50
140
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
+∞
18.4
17
*
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
17.3
16
*
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
210.8
17.2
17
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
19.4
16.4
25
18
WX730
NOMESCO Finland
Conventional respirator
195.4
16.1
16
*
J45.9
ICD-10 Finland
Asthma, unspecified
6.7
15.6
35
82
Z3229
NOMESCO Finland
Other healthcare associate professional
7.5
15.4
28
53
Z2446
NOMESCO Finland
Social worker
6.1
14.4
36
93
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
7.5
14.3
25
45
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
+∞
13.9
13
*
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
+∞
13.9
13
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.3
13.8
31
72
WX408
NOMESCO Finland
General anesthesy, balanced
5.6
13.6
45
147
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.4
12.9
40
123
Z3231
NOMESCO Finland
Registered nurse
5.5
12.9
52
199
6BB16, ,
NOMESCO Finland
151.9
12.8
13
*
R03AC02
ATC
salbutamol; inhalant
8.6
12.7
72
388
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
22.5
12.7
18
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.6
12.7
34
92
Z2221
NOMESCO Finland
Medical doctor
5.4
12.6
38
114
R03AK07
ATC
formoterol and budesonide; inhalant
6.2
12.1
26
57
Z2445
NOMESCO Finland
Psychologist
5.8
11.9
28
67
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.2
11.6
20
35
Z3226
NOMESCO Finland
Physiotherapist
4.9
11.5
40
133
XG413
NOMESCO Finland
Spirometry with oscillometry
16.0
11.3
18
14
WX882
NOMESCO Finland
High dependency care
6.3
11.2
23
48
ZXD10
NOMESCO Finland
Scheduled procedure
4.8
11.1
47
181
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.2
10.4
21
43
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.1
10.3
29
80
ZXD05
NOMESCO Finland
Urgent procedure
4.7
10.2
33
102
ZX108
NOMESCO Finland
Inhalation
62.5
9.9
11
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
20.7
9.8
14
8
ZX114
NOMESCO Finland
Intramuscular
16.3
9.6
15
11
ZXE10
NOMESCO Finland
More than one and less than three hours
4.2
9.2
38
140
P05.1
ICD-10 Finland
Small for gestational age
27.6
9.2
12
5
ZXE00
NOMESCO Finland
One hour or less
4.2
9.2
48
209
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
10.1
9.2
18
22
ZY010
NOMESCO Finland
Hospital outpatient
5.4
9.0
21
49
IGP01
NOMESCO Finland
Psychiatric family contact
5.6
8.6
19
42
RK320, ,
NOMESCO Finland
99.5
8.6
9
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
7.6
8.5
20
33
RK520, ,
NOMESCO Finland
+∞
8.5
8
*
RK312, ,
NOMESCO Finland
+∞
8.5
8
*
RK310, ,
NOMESCO Finland
37.3
8.3
10
*
WX725
NOMESCO Finland
Noninvasive ventilation
15.1
8.2
13
10
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
12.7
8.1
14
13
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
7.6
8.1
19
31
XA800
NOMESCO Finland
Neuropsychological investigation
4.9
8.0
21
54
R03BA05
ATC
fluticasone; inhalant
3.8
7.9
40
166
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.3
7.8
18
41
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.0
7.8
31
109
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
9.2
7.8
16
21
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
7.8
24
70
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.1
7.7
19
46
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.1
7.7
19
46
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
8.7
7.6
16
22
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
87.4
7.5
8
*
R03DC03
ATC
montelukast; oral
4.0
7.4
27
89
WX732
NOMESCO Finland
High frequency respirator
+∞
7.4
7
*
ZX106
NOMESCO Finland
Intranasal
+∞
7.4
7
*
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
+∞
7.4
7
*
ZXA10
NOMESCO Finland
Bilateral
4.1
7.3
26
84
R62.0
ICD-10 Finland
Delayed milestone
4.8
7.3
19
48
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
22.4
7.3
10
5
WW500
NOMESCO Finland
Blood transfusion
10.0
6.8
13
15
RT150, ,
NOMESCO Finland
13.8
6.8
11
9
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
6.8
37
159
WX892
NOMESCO Finland
Monitored bed care
4.8
6.7
17
42
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.8
6.7
17
42
R03AK08
ATC
formoterol and beclometasone; inhalant
16.0
6.6
10
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.2
6.5
14
20
R03BB01
ATC
ipratropium bromide; inhalant
75.2
6.5
7
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.6
6.4
16
29
RK412, ,
NOMESCO Finland
+∞
6.3
6
*
7707A
ICD-9 Finland
Other respiratory conditions of foetus and newborn, Chronic respiratory disease arising in the perinatal period[DYSPLASIA BRONCHOPULMONALIS NEONATALIS]
+∞
6.3
6
*
JFB00
NOMESCO Finland
Partial resection of small intestine
+∞
6.3
6
*
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
+∞
6.3
6
*
P29.31
ICD-10 Finland
Persistent fetal circulation
+∞
6.3
6
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.4
6.3
18
49
R03BB04
ATC
tiotropium bromide; inhalant
14.0
6.2
10
8
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.3
6.2
50
267
UGC02
NOMESCO Finland
Rigid bronchoscopy
16.5
6.0
9
6
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.5
6.0
15
27

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
14
34
4.73
4.45
2.0
2.1
—
—
—
0
0
14
34
4.73
4.45
2.0
2.1
—
—
—
0
0
14
34
4.73
4.45
2.0
2.1
—
—
—
0
0
14
34
4.73
4.45
2.0
2.1
—
—
—
0
0
33
162
2.73
4.45
13.0
14.8
—
—
—
0
0
26
121
2.68
3.81
2.3
1.5
86.30
92.97
pmol/l
0.41
12
61
52
337
2.50
3.76
7.2
15.2
—
—
—
0
0
63
451
2.75
3.62
11.1
15.8
3.40
3.64
e9/l
0.36
54
363
51
332
2.43
3.59
28.1
16.2
1.24
1.23
mmol/l
0.22
46
306
33
177
2.44
3.59
31.1
12.5
7.39
7.41
ph
1.29
27
132
60
427
2.54
3.37
9.4
13.5
0.04
0.04
e9/l
0.28
53
339
60
429
2.51
3.30
9.4
13.5
0.62
0.57
e9/l
0.88
53
341
31
170
2.32
3.14
6.0
14.0
23.64
23.23
mmol/l
0.41
31
170
32
179
2.29
3.09
5.9
14.7
7.37
7.36
ph
0.17
19
109
58
420
2.32
2.92
11.8
16.2
0.00
0.00
e9/l
0.50
50
306
12
40
3.32
2.82
1.5
1.3
—
—
—
0
0
30
170
2.20
2.76
33.3
10.5
24.29
23.95
mmol/l
0.40
30
170
42
277
2.06
2.57
6.4
9.1
—
—
—
0
0
28
160
2.13
2.49
35.0
12.0
—
—
—
0
0
13
52
2.77
2.48
2.0
1.4
—
—
—
0
0
8
22
3.90
2.42
1.8
2.1
—
—
—
0
0
22
118
2.17
2.27
3.8
7.2
2.13
1.96
mg/l
0.06
16
92
6
15
4.21
2.07
3.7
3.8
22.17
20.40
umol/l
—
6
15
22
123
2.07
2.03
4.9
5.1
—
—
—
0
0
22
123
2.07
2.03
5.7
4.1
7.39
7.39
ph
0.23
12
78
5
11
4.74
1.96
1.0
1.0
—
—
—
0
0
32
207
1.89
1.96
42.6
19.6
25.22
24.61
mmol/l
0.51
32
207
8
28
3.04
1.91
1.3
1.1
—
—
—
0
0
6
17
3.70
1.86
1.0
1.0
1.40
1.33
g/l
—
6
17
5
14
3.71
1.63
6.6
8.1
—
—
—
0
0
5
14
3.71
1.63
7.8
2.6
102.60
96.29
mmol/l
—
5
14
6
20
3.14
1.60
6.2
5.9
2.58
2.68
ug/l
—
6
20
5
15
3.46
1.54
3.2
4.7
349.40
409.20
umol/l
—
5
15
33
230
1.72
1.52
3.1
4.2
0.14
0.37
e6/l
0.65
20
157
13
67
2.11
1.46
2.5
1.5
—
—
—
0
0
5
16
3.24
1.45
5.8
5.4
7.41
7.39
ph
—
5
16
44
335
1.67
1.44
4.5
3.4
35.47
35.49
mmol/mol
0.01
39
316
24
156
1.75
1.39
2.5
3.7
2.76
1.75
e6/l
0.37
12
78
34
247
1.64
1.31
3.1
4.6
11.94
29.02
e6/l
0.88
19
175
14
79
1.92
1.25
1.8
2.7
9.00
19.19
ng/l
—
8
33
5
19
2.72
1.22
4.4
4.4
2.22
2.35
mmol/l
—
5
19
14
80
1.90
1.20
20.8
21.1
105.86
105.78
mmol/l
0.02
14
80
6
26
2.40
1.20
1.0
1.0
—
—
—
0
0
15
88
1.85
1.20
13.4
24.1
1.12
1.04
mg/l
0.36
15
88
26
181
1.63
1.16
5.6
4.5
—
—
—
0
0
23
156
1.65
1.13
1.3
1.3
—
—
—
0
0
8
41
2.04
1.11
2.1
2.2
—
—
—
0
0
13
76
1.84
1.05
2.5
2.0
—
—
—
0
0
37
287
1.52
1.03
4.3
5.8
12.52
31.20
e6/l
1.40
21
182
7
35
2.08
1.02
1.6
2.0
—
—
—
0
0
67
599
1.65
0.90
32.6
17.2
4.02
3.94
mmol/l
1.06
67
583
8
43
1.94
0.90
5.5
29.7
1.24
1.18
%
—
8
43
8
43
1.94
0.90
5.8
29.7
0.61
0.56
%
—
8
43
12
72
1.77
0.89
2.7
2.6
—
—
—
0
0
67
601
1.63
0.86
32.7
17.3
139.10
139.33
mmol/l
0.43
67
592
6
33
1.87
0.80
1.0
1.4
—
—
—
0
0
46
390
1.40
0.73
4.1
4.4
—
152.88
—
0
8
7
41
1.76
0.72
38.0
25.0
0.54
0.75
%
—
7
41
7
41
1.76
0.72
38.1
25.1
23.14
23.99
mmol/l
—
7
41
70
643
1.61
0.70
17.3
9.2
—
—
—
0
0
7
43
1.68
0.68
1.1
2.1
19.24
20.44
ng/l
—
7
43
8
51
1.62
0.62
1.9
1.9
—
—
—
0
0
5
30
1.70
0.62
6.6
5.3
61.00
44.13
umol/l
—
5
30
20
151
1.42
0.60
2.8
2.7
—
—
—
0
0
18
136
1.41
0.54
2.7
3.1
612.77
569.05
mosm/kgh2o
0.28
13
113
39
335
1.31
0.52
4.2
2.9
1.12
1.12
mmol/l
0.01
39
314
71
667
1.48
0.48
22.8
14.4
18.98
22.84
mg/l
0.80
61
492
5
31
1.64
0.44
6.2
36.2
88.20
70.67
%
—
5
31
12
88
1.42
0.42
1.2
1.6
—
312.73
—
0
11
24
200
1.28
0.38
3.5
3.8
—
—
—
0
0
10
132
0.72
0.36
4.6
3.7
55.70
58.60
u/l
—
10
122
6
42
1.45
0.36
44.0
24.5
96.68
96.64
%
—
6
42
6
43
1.42
0.36
44.0
24.0
1.00
0.95
%
—
6
43
31
269
1.24
0.35
3.4
3.9
6.36
6.40
ph
0.09
14
122
6
45
1.35
0.34
4.2
4.5
—
—
—
0
0
7
99
0.68
0.33
1.1
1.2
0.09
3.44
u/ml
—
7
79
16
129
1.29
0.32
2.1
1.6
—
—
—
0
0
7
55
1.29
0.31
1.6
2.1
—
—
—
0
0
5
72
0.67
0.27
1.0
1.0
—
—
—
0
0
13
106
1.26
0.24
2.5
2.3
—
—
—
0
0
20
172
1.21
0.24
2.4
4.2
31.87
69.77
ug/g
2.55
15
138
5
37
1.37
0.24
2.8
2.0
60.90
51.07
%
—
5
37
7
91
0.74
0.24
1.1
1.2
0.12
1.13
u/ml
—
7
70
7
91
0.74
0.24
1.1
1.2
6.49
6.00
u/ml
—
7
74
5
38
1.33
0.23
1.0
1.0
—
—
—
0
0
29
319
0.85
0.23
1.7
2.0
1.18
1.36
g/l
0.29
11
162
5
39
1.29
0.23
3.6
6.3
3.26
3.32
mmol/l
—
5
39
16
135
1.22
0.22
13.3
6.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
6502.00
—
0
6
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
13
153
0.82
0.21
2.8
3.4
0.00
0.00
estimate
—
5
47
0
13
0.00
0.21
0.0
1.0
—
0.81
—
0
13
0
13
0.00
0.21
0.0
1.0
—
1.58
—
0
13
0
14
0.00
0.20
0.0
1.6
—
0.00
—
0
6
18
156
1.19
0.20
3.2
3.4
1.02
1.02
kg/l
0.07
11
107
15
172
0.84
0.19
1.9
1.9
—
—
—
0
0
7
61
1.16
0.18
1.6
1.7
—
—
—
0
0
7
61
1.16
0.18
1.7
2.2
—
—
—
0
0
17
148
1.18
0.18
2.8
3.8
8.67
8.86
e6/l
0.02
12
128
8
68
1.19
0.17
2.1
1.7
—
—
—
0
0
34
315
1.13
0.16
3.6
4.2
0.00
0.00
estimate
—
5
54
7
89
0.76
0.15
1.0
1.2
0.16
2.79
u/ml
—
7
71
14
122
1.17
0.14
1.5
1.6
—
—
—
0
0
13
147
0.86
0.13
2.5
2.0
—
—
—
0
0
34
318
1.11
0.13
3.8
4.2
0.00
0.00
estimate
—
5
51
34
320
1.10
0.11
3.8
4.3
0.00
0.00
estimate
—
5
49
5
43
1.17
0.10
3.8
5.8
445.80
369.07
mg/l
—
5
43
5
43
1.17
0.10
1.4
1.2
—
—
—
0
0
20
215
0.90
0.10
3.0
2.3
—
—
—
0
0
5
46
1.09
0.10
1.2
1.1
—
—
—
0
0
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
23
244
0.91
0.08
2.6
2.1
—
—
—
0
0
7
81
0.85
0.07
2.3
1.8
—
—
—
0
0
12
108
1.12
0.07
1.5
1.7
—
—
—
0
0
35
335
1.07
0.06
1.5
2.0
1.48
4.80
u/ml
—
6
48
26
248
1.06
0.04
6.0
4.2
—
—
estimate
—
0
0
12
127
0.93
0.02
3.0
1.9
—
—
—
0
0
15
151
0.99
0.00
3.8
4.4
0.00
0.02
estimate
—
5
52
24
241
0.99
0.00
1.7
1.7
—
—
—
0
0
8
87
0.91
0.00
1.0
1.0
7.29
7.35
mu/l
—
8
87
0
8
0.00
-0.00
0.0
7.0
—
1.00
—
0
8
0
8
0.00
-0.00
0.0
1.7
—
1.43
—
0
8
0
9
0.00
-0.00
0.0
19.6
—
8.28
—
0
9
0
5
0.00
-0.00
0.0
6.6
—
30.40
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
43.14
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
24.16
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
108.78
—
0
9
0
7
0.00
-0.00
0.0
1.1
—
228.14
—
0
7
0
6
0.00
-0.00
0.0
7.3
—
1.24
—
0
6
8
83
0.95
-0.00
2.1
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.8
—
0.56
—
0
5
8
84
0.94
-0.00
2.1
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
36.65
—
0
8
0
9
0.00
-0.00
0.0
3.6
—
0.78
—
0
9
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
2.56
—
0
6
8
82
0.97
-0.00
2.1
1.8
—
—
—
0
0
8
79
1.01
-0.00
2.1
1.7
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint P16_CHRONIC_RESPI_DISEA_ORIGINA_PERINA_PERIOD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_CHRONIC_RESPI_DISEA_ORIGINA_PERINA_PERIOD.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: P16_CHRONIC_RESPI_DISEA_ORIGINA_PERINA_PERIOD – Chronic respiratory disease originating in the perinatal period

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data